CD8A and neoplasm: They efficiently capture exogenous antigens (from viruses, intracellular pathogens, or dead/tumor cells) and present them via MHC class I molecules to activate antigen‐specific CD8+ cytotoxic T lymphocytes (CTLs) [102, 103].